Scott Jordan serves as Executive at Salarius Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Scott Jordan has executed 1 insider transactions totaling $10.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 18, 2020 involved purchasing 11,300 shares valued at $10.2K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 18, 2020 | SLRX | $10.2K | Purchase | 11,300 | $0.90 | Discretionary |
Scott Jordan currently holds 31,609 shares of Salarius Pharmaceuticals, Inc. (SLRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Jordan has been a net buyer of SLRX stock. They have purchased $10.2K and sold $0 worth of shares.
Scott Jordan's most recent insider trade was on Feb 18, 2020, when they purchased 11,300 shares at $0.90 per share.
Get notified when new Form 4 filings are submitted